세계의 유전체학 서비스 시장 보고서(2025년)
Genomics Services Global Market Report 2025
상품코드 : 1825749
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

유전체학 서비스 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 16.5%로 336억 4,000만 달러로 성장할 것입니다. 예측 기간의 성장은 정밀의료의 채택 증가, 복잡한 질병에 대한 연구 집중도 증가, 마이크로바이옴 연구에 대한 관심 증가, 동반진단의 채택 증가, 일상적인 헬스케어에 대한 유전체학의 통합 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 단일세포유전체학의 급속한 발전, 맞춤형 유전체학 서비스의 확대, 멀티오믹스 분석의 통합, 유전체학 해석에 있어 AI와 머신러닝, 클라우드 기반 유전체학 플랫폼 등을 들 수 있습니다.

향후 5년간 16.5%의 성장률 전망은 지난번 예측보다 0.6% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 아이슬란드나 스위스에서 수입되는 전장 엑솜 시퀀싱 및 해석 서비스의 아웃소싱 비용을 증가시키고, 희귀 질환의 진단을 지연시키고, 유전 상담 비용을 증가시킬 수 있기 때문에 미국의 진단 능력에 혼란을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

유전자 치료에 대한 수요 증가는 당분간 유전체학 서비스 시장의 성장을 견인할 것으로 예상됩니다. 유전자 치료는 근본적인 유전적 문제를 해결함으로써 질병의 치료와 예방을 목표로 하는 의료 접근법으로, 근본적인 유전적 원인을 해결함으로써 유전성 질환 및 만성질환의 표적 치료를 제공합니다. 유전체 분석 서비스는 적절한 조직에 대한 타겟팅, 바이러스 벡터의 정량화 및 특성화, 배출 위험 평가 등을 용이하게함으로써 유전자 치료에서 중요한 역할을 하고 있습니다. 예를 들어, 2023년 1월 미국 유전자 및 세포 치료학회(ASGCT)는 유전자 치료제 파이프라인이 6% 확대되었고, 2022년에만 5개의 유전자 치료제가 승인되었다고 보고했습니다. 또한, 유전자, 세포, RNA 치료제 파이프라인은 2022년까지 7% 확대되어 3,726종의 치료제가 개발 중입니다. 따라서 유전자 치료에 대한 수요 증가는 유전체학 서비스 시장의 성장을 뒷받침하는 중요한 촉진요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Genomics services entail the analysis of an individual's genetic material to glean insights into their health, ancestry, and potential disease risks. These services leverage advanced technologies such as deoxyribonucleic acid (DNA) sequencing to decode an individual's genome, offering personalized recommendations for healthcare and lifestyle choices based on genetic information.

The primary products of genomics services encompass instruments or systems, software, and consumables and reagents. Instruments are specialized tools or devices designed for specific tasks or measurements, often within scientific or technical contexts. Systems comprise interconnected components or elements that collaborate to achieve a particular function or objective. Software refers to programs and instructions that enable computers and electronic devices to execute tasks, process data, or manage operations. Various genomics services include gene expression services (RNASeq), epigenomics services, genotyping, next-generation sequencing, Sanger sequencing, and others. These services cater to diverse end-users, predominantly research institutes, healthcare facilities and diagnostic centers, pharmaceutical and biotechnological companies, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genomics services market research report is one of a series of new reports from The Business Research Company that provides genomics services market statistics, including genomics services industry global market size, regional shares, competitors with a genomics services market share, detailed genomics services market segments, market trends and opportunities, and any further data you may need to thrive in the genomics services industry. This genomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics services market size has grown rapidly in recent years. It will grow from $15.51 billion in 2024 to $18.29 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to the advent of next-generation sequencing technologies, increasing focus on genomics in cancer research, advances in pharmacogenomics, increasing applications of genomics in agriculture, and the rise of direct-to-consumer genomics testing services.

The genomics services market size is expected to see rapid growth in the next few years. It will grow to $33.64 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to the increasing adoption of precision medicine, increasing research focus on complex diseases, growing interest in microbiome research, increased adoption of companion diagnostics, and increasing integration of genomics into routine healthcare practices. Major trends in the forecast period include rapid advancements in single-cell genomics, expansion of personalized genomics services, integration of multi-omics analysis, AI and machine learning in genomics interpretation, and cloud-based genomics platforms.

The forecast of 16.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. diagnostic capabilities by increasing costs for outsourced whole exome sequencing and interpretation services imported from Iceland and Switzerland, potentially delaying rare disease diagnoses and increasing genetic counseling expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for gene therapy is expected to drive the growth of the genomics services market in the foreseeable future. Gene therapy, a medical approach aimed at treating or preventing diseases by addressing fundamental genetic issues, offers targeted treatments for genetic disorders and chronic diseases by tackling their underlying genetic causes. Genomic services play a crucial role in gene therapy by facilitating the targeting of correct tissues, quantifying and characterizing viral vectors, and assessing the risk of shedding. For example, in January 2023, The American Society of Gene & Cell Therapy (ASGCT) reported a 6% expansion in the gene therapy pipeline, with the approval of five gene therapies in 2022 alone. Furthermore, the gene, cell, and RNA therapy pipeline saw a 7% expansion in 2022, resulting in 3,726 therapies under development. Hence, the rising demand for gene therapy is a key driver behind the growth of the genomics services market.

Major companies in the genomics services market are focusing on expanding their product portfolios to meet the increasing demand for comprehensive genomic analysis and personalized medicine. This includes offering advanced services such as advanced long-read sequencing services. These services utilize cutting-edge technologies to analyze genetic material with longer sequence reads, enabling more thorough and accurate characterization of DNA and RNA. For instance, in April 2024, Clinical-Microbiomics A/S launched advanced long-read sequencing services tailored to meet the needs of academic, clinical, and industrial researchers. These services, encompassing a wide range of sequencing options, aim to provide unparalleled resolution and quality in microbial analysis, facilitating groundbreaking discoveries in microbiome research.

In December 2023, The Bank of Nova Scotia, a Canada-based banking and financial services company, acquired Bio-Rad Laboratories for an undisclosed amount. Through this acquisition, the Bank of Nova Scotia seeks to expand its portfolio by integrating Bio-Rad Laboratories' expertise in genomics services. Bio-Rad Laboratories Inc., a US-based company, specializes in providing genomics services.

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc.

North America was the largest region in the genomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics services market consists of revenues earned by entities by providing services such as experimental design consultation, library preparation, sequencing services, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics services market also includes sales of DNA sequencing kits, DNA sequencing platforms, bioinformatics tools, and sequencing platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genomics services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomics services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Genomics Services Market Characteristics

3. Genomics Services Market Trends And Strategies

4. Genomics Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomics Services Growth Analysis And Strategic Analysis Framework

6. Genomics Services Market Segmentation

7. Genomics Services Market Regional And Country Analysis

8. Asia-Pacific Genomics Services Market

9. China Genomics Services Market

10. India Genomics Services Market

11. Japan Genomics Services Market

12. Australia Genomics Services Market

13. Indonesia Genomics Services Market

14. South Korea Genomics Services Market

15. Western Europe Genomics Services Market

16. UK Genomics Services Market

17. Germany Genomics Services Market

18. France Genomics Services Market

19. Italy Genomics Services Market

20. Spain Genomics Services Market

21. Eastern Europe Genomics Services Market

22. Russia Genomics Services Market

23. North America Genomics Services Market

24. USA Genomics Services Market

25. Canada Genomics Services Market

26. South America Genomics Services Market

27. Brazil Genomics Services Market

28. Middle East Genomics Services Market

29. Africa Genomics Services Market

30. Genomics Services Market Competitive Landscape And Company Profiles

31. Genomics Services Market Other Major And Innovative Companies

32. Global Genomics Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics Services Market

34. Recent Developments In The Genomics Services Market

35. Genomics Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기